يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"FLOT regimen"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: Malignant tumours; Том 12, № 4 (2022); 5-13 ; Злокачественные опухоли; Том 12, № 4 (2022); 5-13 ; 2587-6813 ; 2224-5057

    وصف الملف: application/pdf

    العلاقة: https://www.malignanttumors.org/jour/article/view/1016/713Test; Reim D, Loos M, Vogl F, et al. Prognostic implications of the seventh edition of the International Union Against Cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol 2013; 31 : 263–71.; Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355 : 11–20.; Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29 : 1715–21.; van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366 : 2074–84.; Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al. Preoperative chemo (radio) therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. Eur J Cancer 2013; 49 : 3149–58.; Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 2010; 28 : 5210–18.; Stark AP, Ikoma N, Chiang YJ et al. Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy. Ann Surg Oncol. 2019 Oct; 26 (11) : 3602–3610. doi : 10.1245/s10434-019-07638-8. Epub 2019 Jul 26. PMID : 31350645.; Becker K, Langer R, Reim D, et al. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg 2011; 253 : 934–39.; Alderson D, Langley RE, Nankivell MG, et al. Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). Proc Am Soc Clin Oncol 2015; 33 (suppl) : 4002 (abstr).; Cunningham D, Smyth E, Stenning S, et al. Peri-operative chemotherapy±bevacizumab for resectable gastro-oesophageal adenocarcinoma: results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948). Eur J Cancer 2015; 51 (suppl 3) : S400.; Donohoe CL, O'Farrell NJ, Grant T, et al. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard. Ann Surg 2013; 258 : 784–92.; https://www.malignanttumors.org/jour/article/view/1016Test

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: ISSN: 1471-2407 ; BMC cancer, vol. 17, no. 1 (2017) 893.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29282088; info:eu-repo/semantics/dataset/url/https://clinicaltrials.gov/ct2/show/NCT02578368Test; https://archive-ouverte.unige.ch/unige:158712Test; unige:158712

  7. 7

    المصدر: BMC cancer, Vol. 21, No 1 (2021) P. 1158
    BMC Cancer
    BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)

    وصف الملف: application/pdf

  8. 8

    المصدر: BMC cancer, Vol. 17, No 1 (2017) P. 893
    BMC Cancer
    BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)

    مصطلحات موضوعية: Cancer Research, Esophageal Neoplasms, medicine.medical_treatment, Adenocarcinoma / therapy, law.invention, Study Protocol, 0302 clinical medicine, Randomized controlled trial, law, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Prospective Studies, Prospective cohort study, Esophageal Neoplasms / pathology, ddc:617, Esophageal Neoplasms / therapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Combined Modality Therapy, Survival Rate, Oncology, Esophagectomy, Lymphatic Metastasis, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Esophagogastric Junction, Quality of life, medicine.medical_specialty, Esophageal Neoplasms / mortality, Adenocarcinoma, lcsh:RC254-282, Adenocarcinoma / mortality, 03 medical and health sciences, Resection of metastases, Stomach Neoplasms, Gastrectomy, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Genetics, medicine, Humans, Progression-free survival, Survival rate, FLOT- regimen, Esophagogastric Junction / pathology, Perioperative chemotherapy, business.industry, Localized peritoneal carcinomatosis, Adenocarcinoma / secondary, Cancer, Limited-metastatic disease, medicine.disease, Surgery, Metastatic gastroesophageal junction cancer, Esophagectomy / mortality, Stomach Neoplasms / mortality, Oligometastatic cancer, Stomach Neoplasms / therapy, Stomach Neoplasms / pathology, business, Metastatic gastric cancer, Gastrectomy / mortality, Follow-Up Studies